Scholarlink

<p>Skin cancer screening is an established secondary prevention measure, but its benefit depends critically on patient selection. While population-wide screening shows limited evidence for mortality reduction, clearly defined high-risk groups benefit from intensified, risk-adapted early detection. These groups include patients with a&#xa0;personal history of melanoma or nonmelanoma skin cancer, positive family history, high nevus count, immunosuppression and individuals with extreme UV exposure. Quality of examination, particularly the use of dermoscopy and digital monitoring in high-risk patients, is crucial for diagnostic yield. Future screening strategies should rely on individual risk factors and allocate resources to vulnerable populations to enable effective, cost-efficient, and patient-centered skin cancer early detection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hautkrebsscreening

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月17日

查看全文
  • Christoph Müller

摘要

Skin cancer screening is an established secondary prevention measure, but its benefit depends critically on patient selection. While population-wide screening shows limited evidence for mortality reduction, clearly defined high-risk groups benefit from intensified, risk-adapted early detection. These groups include patients with a personal history of melanoma or nonmelanoma skin cancer, positive family history, high nevus count, immunosuppression and individuals with extreme UV exposure. Quality of examination, particularly the use of dermoscopy and digital monitoring in high-risk patients, is crucial for diagnostic yield. Future screening strategies should rely on individual risk factors and allocate resources to vulnerable populations to enable effective, cost-efficient, and patient-centered skin cancer early detection.